Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4334 (108th)

To establish a Tick-Borne Disorders Advisory Committee, and for other purposes.

referredUnited States· United States Congress· EN

Introduced

11 May 2004

Last action

21 May 2004 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Kelly, Sue W. [R-NY-19], Rep. Sweeney, John E. [R-NY-20], Sen. Kirk, Mark Steven [R-IL], Rep. McNulty, Michael R. [D-NY-23], Rep. English, Phil [R-PA-3], Rep. McHugh, John M. [R-NY-23], Rep. Hinchey, Maurice D. [D-NY-22], Rep. McCarthy, Carolyn [D-NY-4], Rep. Wolf, Frank R. [R-VA-10], Rep. Payne, Donald M. [D-NJ-10], Rep. Wexler, Robert [D-FL-19], Rep. Hastings, Alcee L. [D-FL-20], Rep. Delahunt, William D. [D-MA-10], Rep. Frank, Barney [D-MA-4], Rep. Bradley, Jeb [R-NH-1], Rep. Kildee, Dale E. [D-MI-5]

Subjects

Healthcare

Source updated

2 January 2025

Healthcare

Summary

Establishes the Tick-Borne Disorders Advisory Committee in the Office of the Secretary of the Department of Health and Human Services (HHS). Directs the Committee to advise the Secretary and the Assistant Secretary of HHS regarding how to: (1) assure interagency coordination and communication in efforts to address tick-borne disorders; (2) identify opportunities to coordinate efforts with other Federal agencies and private organizations; and (3) develop informed responses to constituency groups regarding HHS' efforts and progress. Authorizes appropriations for FY 2004 and 2005 to fund the Committee in accordance with the Federal Advisory Committee Act. Authorizes appropriations for FY 2004 through 2008 for: (1) research and educational activities concerning Lyme disease and other tick-borne disorders; and (2) efforts to prevent such illnesses. Expresses the sense of Congress that the Secretary should consider carrying out a five-year plan to: (1) develop a diagnostic test for Lyme disease and other tick-borne disorders for use in clinical testing; (2) determine the prevalence of such illnesses in the United States; and (3) develop the capabilities at HHS to design and implement improved strategies for the prevention and control of such illnesses.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 May 2004

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 11 May 2004

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 11 May 2004

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 21 May 2004

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 11 May 2004

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 11 May 2004

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 11 May 2004

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.